Global Chemotherapy Devices research

Chemotherapy Devices Comprehensive Study by Type (LVP (Large Volume Pump), Syringe Pump, Elastomeric Pumps), Application (Hospital & Clinic, Home Care), Cancer Type (Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Other) Players and Region - Global Market Outlook to 2024

Chemotherapy Devices Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Chemotherapy Devices Market Overview:
Chemotherapy device is a point-of-care and implantable devices for cancer treatment to destroy rapidly growing cells in the body. Rapid innovations in chemotherapy devices and technological advancement have encouraged doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines. According to National Cancer Institutes, an estimated 1,735,350 new cases of cancer will be diagnosed in the United States and 609,640 people will die from the disease in the year 2018. Some of the key players profiled in the study are ICU Medical (United States), Becton, Dickinson and Company (United States), Terumo Corporation (Japan), B. Braun (Germany), Halyard Health (United States), Smiths Group (United Kingdom), Baxter International (United States), Fresenius (Germany), Moog Inc. (United States), Zyno Medical (United States), Micrel Medical (Greece) and Advanced Chemotherapy Technologies (United States).

On the basis of geography, the market of Chemotherapy Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Cancer Type, the sub-segment i.e. Blood Cancer will boost the Chemotherapy Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • The Rising Occurrence of Various Types of Cancer Including Sarcoma, Lung Cancer, Lymphoma, Myeloma, and Breast Cancer
  • Surging Investment on Research and Development in Oncology

Market Trend
  • Increasing Government Initiatives and Technological Advancements in the Chemotherapy Devices
  • The Growing Economic Burden of the Disease, Especially among Geriatric Patient Populations

Restraints
  • Unwillingness Showed by Patients to Undergo Chemotherapy
  • Rise in Risk of Infection

Opportunities
  • Growing Number of Randomized Clinical Trials in Both Developed and Developing Economies

Challenges
  • Lack of Proper Reimbursement Policies in the Developing Countries
  • Dearth of Skilled Professionals in Emerging Nations




Target Audience:
Chemotherapy Devices Manufacturers, Chemotherapy Devices Distributors/Suppliers, Hospitals, Research Organizations, End-Users, Government Bodies and Others

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Chemotherapy Devices market on the basis of product [LVP (Large Volume Pump), Syringe Pump and Elastomeric Pumps] , application [Hospital & Clinic and Home Care], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Chemotherapy Devices market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Chemotherapy Devices industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Chemotherapy Devices market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.

Report Objectives / Segmentation Covered

By Type
  • LVP (Large Volume Pump)
  • Syringe Pump
  • Elastomeric Pumps
By Application
  • Hospital & Clinic
  • Home Care
By Cancer Type
  • Blood Cancer
  • Breast Cancer
  • Prostate Cancer
  • Gastrointestinal Cancer
  • Gynecologic Cancer
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Rising Occurrence of Various Types of Cancer Including Sarcoma, Lung Cancer, Lymphoma, Myeloma, and Breast Cancer
      • 3.2.2. Surging Investment on Research and Development in Oncology
    • 3.3. Market Challenges
      • 3.3.1. Lack of Proper Reimbursement Policies in the Developing Countries
      • 3.3.2. Dearth of Skilled Professionals in Emerging Nations
    • 3.4. Market Trends
      • 3.4.1. Increasing Government Initiatives and Technological Advancements in the Chemotherapy Devices
      • 3.4.2. The Growing Economic Burden of the Disease, Especially among Geriatric Patient Populations
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Chemotherapy Devices, by Type, Application, Cancer Type and Region (value and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Chemotherapy Devices (Value)
      • 5.2.1. Global Chemotherapy Devices by: Type (Value)
        • 5.2.1.1. LVP (Large Volume Pump)
        • 5.2.1.2. Syringe Pump
        • 5.2.1.3. Elastomeric Pumps
      • 5.2.2. Global Chemotherapy Devices by: Application (Value)
        • 5.2.2.1. Hospital & Clinic
        • 5.2.2.2. Home Care
      • 5.2.3. Global Chemotherapy Devices by: Cancer Type (Value)
        • 5.2.3.1. Blood Cancer
        • 5.2.3.2. Breast Cancer
        • 5.2.3.3. Prostate Cancer
        • 5.2.3.4. Gastrointestinal Cancer
        • 5.2.3.5. Gynecologic Cancer
        • 5.2.3.6. Other
      • 5.2.4. Global Chemotherapy Devices Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Chemotherapy Devices (Price)
      • 5.3.1. Global Chemotherapy Devices by: Type (Price)
  • 6. Chemotherapy Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. ICU Medical (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Becton, Dickinson and Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Terumo Corporation (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. B. Braun (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Halyard Health (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Smiths Group (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Baxter International (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Fresenius (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Moog Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Zyno Medical (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Micrel Medical (Greece)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Advanced Chemotherapy Technologies (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Chemotherapy Devices Sale, by Type, Application, Cancer Type and Region (value and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Chemotherapy Devices (Value)
      • 7.2.1. Global Chemotherapy Devices by: Type (Value)
        • 7.2.1.1. LVP (Large Volume Pump)
        • 7.2.1.2. Syringe Pump
        • 7.2.1.3. Elastomeric Pumps
      • 7.2.2. Global Chemotherapy Devices by: Application (Value)
        • 7.2.2.1. Hospital & Clinic
        • 7.2.2.2. Home Care
      • 7.2.3. Global Chemotherapy Devices by: Cancer Type (Value)
        • 7.2.3.1. Blood Cancer
        • 7.2.3.2. Breast Cancer
        • 7.2.3.3. Prostate Cancer
        • 7.2.3.4. Gastrointestinal Cancer
        • 7.2.3.5. Gynecologic Cancer
        • 7.2.3.6. Other
      • 7.2.4. Global Chemotherapy Devices Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Chemotherapy Devices (Price)
      • 7.3.1. Global Chemotherapy Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Chemotherapy Devices: by Type(USD Million)
  • Table 2. Chemotherapy Devices LVP (Large Volume Pump) , by Region USD Million (2013-2018)
  • Table 3. Chemotherapy Devices Syringe Pump , by Region USD Million (2013-2018)
  • Table 4. Chemotherapy Devices Elastomeric Pumps , by Region USD Million (2013-2018)
  • Table 5. Chemotherapy Devices: by Application(USD Million)
  • Table 6. Chemotherapy Devices Hospital & Clinic , by Region USD Million (2013-2018)
  • Table 7. Chemotherapy Devices Home Care , by Region USD Million (2013-2018)
  • Table 8. Chemotherapy Devices: by Cancer Type(USD Million)
  • Table 9. Chemotherapy Devices Blood Cancer , by Region USD Million (2013-2018)
  • Table 10. Chemotherapy Devices Breast Cancer , by Region USD Million (2013-2018)
  • Table 11. Chemotherapy Devices Prostate Cancer , by Region USD Million (2013-2018)
  • Table 12. Chemotherapy Devices Gastrointestinal Cancer , by Region USD Million (2013-2018)
  • Table 13. Chemotherapy Devices Gynecologic Cancer , by Region USD Million (2013-2018)
  • Table 14. Chemotherapy Devices Other , by Region USD Million (2013-2018)
  • Table 15. South America Chemotherapy Devices, by Country USD Million (2013-2018)
  • Table 16. South America Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 17. South America Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 18. South America Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 19. Brazil Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 20. Brazil Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 21. Brazil Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 22. Argentina Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 23. Argentina Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 24. Argentina Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 25. Rest of South America Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 26. Rest of South America Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 27. Rest of South America Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 28. Asia Pacific Chemotherapy Devices, by Country USD Million (2013-2018)
  • Table 29. Asia Pacific Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 30. Asia Pacific Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 31. Asia Pacific Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 32. China Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 33. China Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 34. China Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 35. Japan Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 36. Japan Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 37. Japan Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 38. India Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 39. India Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 40. India Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 41. South Korea Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 42. South Korea Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 43. South Korea Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 44. Taiwan Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 45. Taiwan Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 46. Taiwan Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 47. Australia Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 48. Australia Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 49. Australia Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 50. Rest of Asia-Pacific Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 51. Rest of Asia-Pacific Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 52. Rest of Asia-Pacific Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 53. Europe Chemotherapy Devices, by Country USD Million (2013-2018)
  • Table 54. Europe Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 55. Europe Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 56. Europe Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 57. Germany Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 58. Germany Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 59. Germany Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 60. France Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 61. France Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 62. France Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 63. Italy Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 64. Italy Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 65. Italy Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 66. United Kingdom Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 67. United Kingdom Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 68. United Kingdom Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 69. Netherlands Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 70. Netherlands Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 71. Netherlands Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 72. Rest of Europe Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 73. Rest of Europe Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 74. Rest of Europe Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 75. MEA Chemotherapy Devices, by Country USD Million (2013-2018)
  • Table 76. MEA Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 77. MEA Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 78. MEA Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 79. Middle East Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 80. Middle East Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 81. Middle East Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 82. Africa Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 83. Africa Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 84. Africa Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 85. North America Chemotherapy Devices, by Country USD Million (2013-2018)
  • Table 86. North America Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 87. North America Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 88. North America Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 89. United States Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 90. United States Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 91. United States Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 92. Canada Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 93. Canada Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 94. Canada Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 95. Mexico Chemotherapy Devices, by Type USD Million (2013-2018)
  • Table 96. Mexico Chemotherapy Devices, by Application USD Million (2013-2018)
  • Table 97. Mexico Chemotherapy Devices, by Cancer Type USD Million (2013-2018)
  • Table 98. Chemotherapy Devices: by Type(USD/Units)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Chemotherapy Devices: by Type(USD Million)
  • Table 112. Chemotherapy Devices LVP (Large Volume Pump) , by Region USD Million (2019-2024)
  • Table 113. Chemotherapy Devices Syringe Pump , by Region USD Million (2019-2024)
  • Table 114. Chemotherapy Devices Elastomeric Pumps , by Region USD Million (2019-2024)
  • Table 115. Chemotherapy Devices: by Application(USD Million)
  • Table 116. Chemotherapy Devices Hospital & Clinic , by Region USD Million (2019-2024)
  • Table 117. Chemotherapy Devices Home Care , by Region USD Million (2019-2024)
  • Table 118. Chemotherapy Devices: by Cancer Type(USD Million)
  • Table 119. Chemotherapy Devices Blood Cancer , by Region USD Million (2019-2024)
  • Table 120. Chemotherapy Devices Breast Cancer , by Region USD Million (2019-2024)
  • Table 121. Chemotherapy Devices Prostate Cancer , by Region USD Million (2019-2024)
  • Table 122. Chemotherapy Devices Gastrointestinal Cancer , by Region USD Million (2019-2024)
  • Table 123. Chemotherapy Devices Gynecologic Cancer , by Region USD Million (2019-2024)
  • Table 124. Chemotherapy Devices Other , by Region USD Million (2019-2024)
  • Table 125. South America Chemotherapy Devices, by Country USD Million (2019-2024)
  • Table 126. South America Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 127. South America Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 128. South America Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 129. Brazil Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 130. Brazil Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 131. Brazil Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 132. Argentina Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 133. Argentina Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 134. Argentina Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 135. Rest of South America Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 136. Rest of South America Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 137. Rest of South America Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 138. Asia Pacific Chemotherapy Devices, by Country USD Million (2019-2024)
  • Table 139. Asia Pacific Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 140. Asia Pacific Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 141. Asia Pacific Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 142. China Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 143. China Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 144. China Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 145. Japan Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 146. Japan Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 147. Japan Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 148. India Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 149. India Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 150. India Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 151. South Korea Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 152. South Korea Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 153. South Korea Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 154. Taiwan Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 155. Taiwan Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 156. Taiwan Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 157. Australia Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 158. Australia Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 159. Australia Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 160. Rest of Asia-Pacific Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 161. Rest of Asia-Pacific Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 162. Rest of Asia-Pacific Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 163. Europe Chemotherapy Devices, by Country USD Million (2019-2024)
  • Table 164. Europe Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 165. Europe Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 166. Europe Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 167. Germany Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 168. Germany Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 169. Germany Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 170. France Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 171. France Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 172. France Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 173. Italy Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 174. Italy Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 175. Italy Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 176. United Kingdom Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 177. United Kingdom Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 178. United Kingdom Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 179. Netherlands Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 180. Netherlands Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 181. Netherlands Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 182. Rest of Europe Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 183. Rest of Europe Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 184. Rest of Europe Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 185. MEA Chemotherapy Devices, by Country USD Million (2019-2024)
  • Table 186. MEA Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 187. MEA Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 188. MEA Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 189. Middle East Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 190. Middle East Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 191. Middle East Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 192. Africa Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 193. Africa Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 194. Africa Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 195. North America Chemotherapy Devices, by Country USD Million (2019-2024)
  • Table 196. North America Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 197. North America Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 198. North America Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 199. United States Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 200. United States Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 201. United States Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 202. Canada Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 203. Canada Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 204. Canada Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 205. Mexico Chemotherapy Devices, by Type USD Million (2019-2024)
  • Table 206. Mexico Chemotherapy Devices, by Application USD Million (2019-2024)
  • Table 207. Mexico Chemotherapy Devices, by Cancer Type USD Million (2019-2024)
  • Table 208. Chemotherapy Devices: by Type(USD/Units)
  • Table 209. Research Programs/Design for This Report
  • Table 210. Key Data Information from Secondary Sources
  • Table 211. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Chemotherapy Devices: by Type USD Million (2013-2018)
  • Figure 5. Global Chemotherapy Devices: by Application USD Million (2013-2018)
  • Figure 6. Global Chemotherapy Devices: by Cancer Type USD Million (2013-2018)
  • Figure 7. South America Chemotherapy Devices Share (%), by Country
  • Figure 8. Asia Pacific Chemotherapy Devices Share (%), by Country
  • Figure 9. Europe Chemotherapy Devices Share (%), by Country
  • Figure 10. MEA Chemotherapy Devices Share (%), by Country
  • Figure 11. North America Chemotherapy Devices Share (%), by Country
  • Figure 12. Global Chemotherapy Devices: by Type USD/Units (2013-2018)
  • Figure 13. Global Chemotherapy Devices share by Players 2018 (%)
  • Figure 14. Global Chemotherapy Devices share by Players (Top 3) 2018(%)
  • Figure 15. Global Chemotherapy Devices share by Players (Top 5) 2018(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. ICU Medical (United States) Revenue, Net Income and Gross profit
  • Figure 18. ICU Medical (United States) Revenue: by Geography 2018
  • Figure 19. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 20. Becton, Dickinson and Company (United States) Revenue: by Geography 2018
  • Figure 21. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 22. Terumo Corporation (Japan) Revenue: by Geography 2018
  • Figure 23. B. Braun (Germany) Revenue, Net Income and Gross profit
  • Figure 24. B. Braun (Germany) Revenue: by Geography 2018
  • Figure 25. Halyard Health (United States) Revenue, Net Income and Gross profit
  • Figure 26. Halyard Health (United States) Revenue: by Geography 2018
  • Figure 27. Smiths Group (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Smiths Group (United Kingdom) Revenue: by Geography 2018
  • Figure 29. Baxter International (United States) Revenue, Net Income and Gross profit
  • Figure 30. Baxter International (United States) Revenue: by Geography 2018
  • Figure 31. Fresenius (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Fresenius (Germany) Revenue: by Geography 2018
  • Figure 33. Moog Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Moog Inc. (United States) Revenue: by Geography 2018
  • Figure 35. Zyno Medical (United States) Revenue, Net Income and Gross profit
  • Figure 36. Zyno Medical (United States) Revenue: by Geography 2018
  • Figure 37. Micrel Medical (Greece) Revenue, Net Income and Gross profit
  • Figure 38. Micrel Medical (Greece) Revenue: by Geography 2018
  • Figure 39. Advanced Chemotherapy Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 40. Advanced Chemotherapy Technologies (United States) Revenue: by Geography 2018
  • Figure 41. Global Chemotherapy Devices: by Type USD Million (2019-2024)
  • Figure 42. Global Chemotherapy Devices: by Application USD Million (2019-2024)
  • Figure 43. Global Chemotherapy Devices: by Cancer Type USD Million (2019-2024)
  • Figure 44. South America Chemotherapy Devices Share (%), by Country
  • Figure 45. Asia Pacific Chemotherapy Devices Share (%), by Country
  • Figure 46. Europe Chemotherapy Devices Share (%), by Country
  • Figure 47. MEA Chemotherapy Devices Share (%), by Country
  • Figure 48. North America Chemotherapy Devices Share (%), by Country
  • Figure 49. Global Chemotherapy Devices: by Type USD/Units (2019-2024)
List of companies from research coverage that are profiled in the study
  • ICU Medical (United States)
  • Becton, Dickinson and Company (United States)
  • Terumo Corporation (Japan)
  • B. Braun (Germany)
  • Halyard Health (United States)
  • Smiths Group (United Kingdom)
  • Baxter International (United States)
  • Fresenius (Germany)
  • Moog Inc. (United States)
  • Zyno Medical (United States)
  • Micrel Medical (Greece)
  • Advanced Chemotherapy Technologies (United States)
Select User Access Type

Key Highlights of Report


Jul 2019 239 Pages 78 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Chemotherapy Devices research Quantitative research analysis
Global Chemotherapy Devices research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Chemotherapy Devices research Report?

Have a Query? Click Here

Other Related Reports

Nicotine Patch Comprehensive Study by Type (16-hour patches, 24-hour patches), Application (Male, Female), Age Limit (Age Below 30, Age 30-50, Age above 50), Sales Channel (Supermarkets, Pharmacy sto...
$ 3450
Virtual 3D Nanorobots Comprehensive Study by Type (Microbivore Nanorobots, Respirocyte Nanorobots, Clottocyte Nanorobots), Application (Dentistry, Emerging Drug Delivery, Brain Aneurysm, Cancer detec...
$ 3650
Dental 3D Printing Devices Comprehensive Study by Type (Printers, Software, Components), Application (Orthopedic Implants, Dental Restoratives), Technique (Digital Light Projection, 3D Jet Printing, ...
$ 3750
Medical Aesthetic Devices Comprehensive Study by Type (Energy-based Aesthetic Device(Radiofrequency (RF)-based Aesthetic Device, Light-based Aesthetic Device, Ultrasound Aesthetic Device), Non-energy...
$ 3750
Hearing Amplifiers Comprehensive Study by Type (Behind-the-ear (BTE), Receiver-In-Ear (Ric), Completely-In-Canal, Around The Neck), Application (Hearing Impaired Patients, The Elderly, Others), Funct...
$ 3650
Dental Loupe Comprehensive Study by Type (Clip-On Loupe, Headband Mounted Loupe), Application (Hospitals, Dental Clinics, Ambulatory Surgical Centers), Distribution Channel (E-Platform, Medical Store...
$ 3500